| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |